Fri, February 18, 2022
Thu, February 17, 2022
Wed, February 16, 2022
Tue, February 15, 2022
Mon, February 14, 2022
Fri, February 11, 2022
Thu, February 10, 2022
Wed, February 9, 2022

Tejas Savant Maintained (AKYA) at Buy with Decreased Target to $20 on, Feb 15th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-20-on-feb-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Tejas Savant of Morgan Stanley, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $24 to $20 on, Feb 15th, 2022.

Tejas, nor any peers, have made any analyst calls on AKYA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources